Literature DB >> 6611160

Cellular mechanism of DNA-specific antibody synthesis by lymphocytes from systemic lupus erythematosus patients.

T Takeuchi, T Abe, J Koide, O Hosono, C Morimoto, M Homma.   

Abstract

The cellular mechanism of anti-DNA antibody synthesis in patients with systemic lupus erythematosus (SLE) was studied by DNA-specific solid-phase radioimmunoassay. Anti-DNA antibody synthesis in response to DNA was T-dependent, and the experiments with reconstituted lymphocytes from identical twins discordant for SLE showed that B cells and T cells from SLE patients must cooperate to synthesize anti-DNA antibody. Anti-DNA antibody synthesis by lymphocytes from patients with inactive SLE was enhanced by T4 cells and suppressed by T8 cells in response to DNA. Although T4 cells from patients with active SLE could enhance anti-DNA antibody synthesis by autologous B cells, their T8 cells could not suppress anti-DNA antibody synthesis by autologous B cells. These results indicate that elevated anti-DNA antibody synthesis in response to DNA in patients with active SLE is due to abnormalities of both SLE B cells and SLE T cells. They further indicate that dysfunction of T8 cells from patients with active SLE may, in part, be responsible for deficient regulation of anti-DNA antibody synthesis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6611160     DOI: 10.1002/art.1780270707

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  10 in total

1.  Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus.

Authors:  Hiroshi Kato; Andras Perl
Journal:  J Immunol       Date:  2014-03-28       Impact factor: 5.422

2.  Evaluation of serum levels of soluble interleukin-2 receptor as an indicator of disease activity in systemic lupus erythematosus.

Authors:  P Airŏ; S Braga; E Prati; D Brugnoni; M Bettinzioli; R Gorla; R Cattaneo
Journal:  Clin Rheumatol       Date:  1992-03       Impact factor: 2.980

Review 3.  Type I interferon in the pathogenesis of lupus.

Authors:  Mary K Crow
Journal:  J Immunol       Date:  2014-06-15       Impact factor: 5.422

4.  Accessory cell activity of monocytes in anti-DNA antibody production in systemic lupus erythematosus.

Authors:  T Sasaki; S Shibata; Y Hirabayashi; Y Sekiguchi; K Yoshinaga
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

5.  Specific suppression of anti-DNA production in vitro.

Authors:  M R Liebling; C Wong; J Radosevich; J S Louie
Journal:  J Clin Immunol       Date:  1988-09       Impact factor: 8.317

6.  Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression.

Authors:  A Kitani; M Hara; T Hirose; M Harigai; K Suzuki; M Kawakami; Y Kawaguchi; T Hidaka; M Kawagoe; H Nakamura
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

7.  Ongoing immunoglobulin class switch DNA recombination in lupus B cells: analysis of switch regulatory regions.

Authors:  Paolo Casali; Mary K Crow; Shiquan Liu; Andrea Cerutti
Journal:  Autoimmunity       Date:  2004 Sep-Nov       Impact factor: 2.815

8.  Cellular regulation of anti-nRNP antibody synthesis is different from that of anti-DNA antibody synthesis in patients with systemic lupus erythematosus.

Authors:  O Hosono; T Takeuchi; J Koide; M Takano; T Abe
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

Review 9.  From autoinflammation to autoimmunity: old and recent findings.

Authors:  Francesco Caso; Luisa Costa; Valeria Nucera; Giuseppe Barilaro; Ignazio Francesco Masala; Rossella Talotta; Paolo Caso; Raffaele Scarpa; Piercarlo Sarzi-Puttini; Fabiola Atzeni
Journal:  Clin Rheumatol       Date:  2018-07-16       Impact factor: 2.980

10.  Longitudinal analysis of peripheral blood T cell receptor diversity in patients with systemic lupus erythematosus by next-generation sequencing.

Authors:  Dharma R Thapa; Raffi Tonikian; Chao Sun; Mei Liu; Andrea Dearth; Michelle Petri; Francois Pepin; Ryan O Emerson; Ann Ranger
Journal:  Arthritis Res Ther       Date:  2015-05-23       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.